natgillin/translations-raw huggingface dataset:
The use of zoledronic acid in patients with severe renal impairment (creatinine clearance < 35 ml/min) is contraindicated due to an increased risk of renal failure in this population
Primjena zoledronatne kiseline u bolesnika s teškim oštećenjem bubrega (klirens kreatinina < 35 ml/min), kontraindicirana je zbog povećanog rizika od zatajenja bubrega u toj populaciji.
The use of zoledronic acid in patients with severe renal impairment (creatinine clearance < 35 ml/min) is contraindicated due to an increased risk of renal failure in this population.
Primjena zoledronatne kiseline u bolesnika s teškim oštećenjem funkcije bubrega (klirens kreatinina < 35 ml/min) kontraindicirana je zbog povećanog rizika od zatajenja bubrega u toj populaciji.
The use of Zoledronic acid Teva Generics in patients with severe renal impairment (creatinine clearance < 35 ml/min) is contraindicated due to an increased risk of renal failure in this population.
Primjena Zoledronatne kiseline Teva Generics u bolesnika s teškim oštećenjem funkcije bubrega (klirens kreatinina < 35ml/min) kontraindicirana je zbog povećanog rizika od zatajenja bubrega u toj populaciji.
The use of Zoledronic acid Teva Pharma in patients with severe renal impairment (creatinine clearance < 35 ml/min) is contraindicated due to an increased risk of renal failure in this population.
Primjena Zoledronatne kiseline Teva Pharma u bolesnika s teškim oštećenjem funkcije bubrega (klirens kreatinina < 35ml/min) kontraindicirana je zbog povećanog rizika od zatajenja bubrega u toj populaciji.
The use of Zomarist in children and adolescents up to 18 years of age is not recommended.
Zomarist se ne preporučuje za primjenu u djece i adolescenata ispod 18 godina.
The use of Zykadia in children and adolescents up to 18 years of age is not recommended.
Ne preporučuje se primjena Zykadie u djece i adolescenata do 18 godina starosti.
The use of Zykadia in the treatment of ALK-positive NSCLC patients previously treated with an ALK inhibitor was investigated in two global, multicentre, open-label, single-arm studies (Study A and Study B).
Primjena Zykadie u liječenju bolesnika s ALK-pozitivnim NSCLC-om koji su prethodno bili liječeni ALK inhibitorom ispitivana je u dva globalna, multicentrična, otvorena ispitivanja s jednom skupinom (Ispitivanje A i Ispitivanje B).
The use of ZYPADHERA in elderly patients with dementia (confusion and memory loss) is not recommended as it may have serious side effects.
Ne preporučuje se primjena lijeka ZYPADHERA u starijih bolesnika s demencijom (smetenost i gubitak pamćenja) jer može imati ozbiljne nuspojave.
The use of ZYPREXA in elderly patients with dementia (confusion and memory loss) is not recommended as it may have serious side effects.
Primjena lijeka ZYPREXA u starijih bolesnika s demencijom (smetenošću i zaboravljivošću) se ne preporučuje jer mogu nastati teške nuspojave.
The use of ZYPREXA in elderly patients with dementia is not recommended as it may have serious side effects.
Primjena lijeka ZYPREXA u starijih bolesnika s demencijom (zaboravljivošću) se ne preporučuje jer mogu nastati teške nuspojave.
The use of ZYPREXA VELOTAB in elderly patients with dementia is not recommended as it may have serious side effects.
Primjena lijeka ZYPREXA VELOTAB u starijih bolesnika s demencijom (zaboravljivošću) se ne preporučuje jer mogu nastati teške nuspojave.
The use of ZYTIGA should be cautiously assessed in patients with moderate hepatic impairment, in whom the benefit clearly should outweigh the possible risk (see sections 4.2 and 5.2).
Primjenu lijeka ZYTIGA u bolesnika s umjerenim oštećenjem jetre, u kojih korist primjene mora jasno nadvladati mogući rizik, mora se pažljivo procijeniti (vidjeti dijelove 4.2 i 5.2).
The used administration system in the closed outer package and the battery are then to be disposed of according to local requirements.
Upotrijebljen sustav za primjenu u zatvorenom vanjskom pakiranju i bateriju zatim treba zbrinuti sukladno lokalnim propisima.
The used administration system in the closed outer package and the battery are then to be disposed of according to local requirements.
Upotrijebljeni sustav za primjenu u zatvorenom vanjskom pakiranju i bateriju zatim treba zbrinuti sukladno lokalnim propisima.
The used OptiSet must be discarded as required by your local authorities.
Upotrijebljenu OptiSet brizgalicu potrebno je ukloniti sukladno lokalnim propisima.
The used OptiSet must be discarded as required by your local authorities.
Upotrijebljenu OptiSet brizgalicu potrebno je zbrinuti sukladno lokalnim propisima.
The used patches should be folded in half, adhesive side inwards so that the release membrane is not exposed, placed in the original sachet and then discarded safely out of the reach of children.
Iskorištene flastere treba saviti napola, s ljepljivom stranom prema unutra tako da membrana koja otpušta lijek nije izložena, staviti u originalnu vrećicu i zatim zbrinuti na siguran način izvan dohvata djece.
The used Pen may be discarded in your household trash after you have removed the Needle.
Upotrijebljenu brizgalicu možete baciti u kućni otpad nakon što uklonite iglu.
The used Pen may be discarded in your household waste after you have removed the Needle.
Upotrijebljenu brizgalicu možete baciti u kućni otpad nakon što uklonite iglu
The used Pen may be discarded in your household waste after you have removed the Needle.
Upotrijebljenu brizgalicu možete baciti u kućni otpad nakon što uklonite iglu.
The used pre-filled pen should be disposed of in accordance with local requirements.
Iskorištene brizgalice treba ukloniti u skladu s lokalnim propisima.
The used pre-filled syringe and any gauze or tissue with Kineret solution should be disposed of in accordance with local requirements.
Korištenu napunjenu štrcaljku i sve gaze i maramice s otopinom Kinereta valja zbrinuti u skladu s lokalnim propisima.
The used pre-filled syringe should be disposed of in accordance with local requirements.
Iskorištene napunjene štrcaljke treba ukloniti u skladu s lokalnim propisima.
The used pre-filled syringe should be disposed of in accordance with local requirements.
Korištenu napunjenu štrcaljku valja zbrinuti u skladu s lokalnim zahtjevima.
The used syringe should be disposed of in accordance with local requirements.
Iskorištena štrcaljka treba se zbrinuti u skladu s lokalnim propisima.
The used syringe should be disposed of in accordance with local requirements.
Iskorištene štrcaljke treba zbrinuti u skladu s lokalnim propisima.
The used transdermal patch will still contain some granisetron and should be disposed of immediately as described in section 5.
Iskorišteni transdermalni flaster još sadrži nešto granisetrona i treba ga odmah baciti kako je opisano u dijelu 5.
The user may not be protected from pregnancy.
Žena možda nije zaštićena od trudnoće.
The usual adult dose is 400 mg/100 mg twice a day i.e. every 12 hours, in combination with other anti- HIV medicines.
Uobičajena doza za odrasle je 400 mg/100 mg dva puta dnevno, tj. svakih 12 sati u kombinaciji s drugim anti- HIV lijekovima.
The usual adult dose is 400 mg/100 mg twice a day i.e. every 12 hours, in combination with other anti-HIV medicines.
Uobičajena doza za odrasle je 400 mg/100 mg dva puta dnevno tj. svakih 12 sati u kombinaciji s drugim anti- HIV lijekovima.
The usual adult dose is 400 mg/100 mg twice a day i.e. every 12 hours, in combination with other anti-HIV medicines.
Uobičajena doza za odrasle je 400 mg/100 mg dva puta dnevno, tj. svakih 12 sati u kombinaciji s drugim anti- HIV lijekovima.
The usual adult dose is 5 ml of the oral solution twice a day i.e. every 12 hours, in combination with other anti-HIV medicines.
Uobičajena doza za odrasle je 5 ml oralne otopine dva puta dnevno, tj. svakih 12 sati u kombinaciji s drugim anti-HIV lijekovima.
The usual aseptic precautions should be applied to all administration methods.
Prilikom svake primjene treba poštivati pravila aseptičnog postupka.
The usual daily dose for EXJADE dispersible tablets at the start of the treatment for patients not receiving regular blood transfusions is 10 mg per kilogram body weight.
Uobičajena dnevna doza EXJADE tableta za oralnu suspenziju na početku liječenja za bolesnike koji ne primaju redovite transfuzije krvi je 10 mg po kilogramu tjelesne težine.
The usual daily dose for EXJADE dispersible tablets at the start of the treatment for patients receiving regular blood transfusions is 20 mg per kilogram body weight.
Uobičajena dnevna doza EXJADE tableta za oralnu suspenziju na početku liječenja za bolesnike koji primaju redovite transfuzije krvi je 20 mg po kilogramu tjelesne težine.
The usual daily dose for EXJADE film-coated tablets at the start of the treatment for patients not receiving regular blood transfusions is 7 mg per kilogram body weight.
Uobičajena dnevna doza EXJADE filmom obloženih tableta na početku liječenja za bolesnike koji ne primaju redovite transfuzije krvi je 7 mg po kilogramu tjelesne težine.
The usual daily dose for EXJADE film-coated tablets at the start of the treatment for patients receiving regular blood transfusions is 14 mg per kilogram body weight.
Uobičajena dnevna doza EXJADE filmom obloženih tableta na početku liječenja za bolesnike koji primaju redovite transfuzije krvi je 14 mg po kilogramu tjelesne težine.
The usual daily dose is 6 to 8 mg per kg for a child with a body weight of up to 55 kg or 300 to 500 mg for a child with a body weight more than 55 kg (which ever dose is lower) taken once a day.
Uobičajena dnevna doza iznosi 6 mg do 8 mg po kilogramu za djecu tjelesne težine do 55 kg ili od 300 do 500 mg za djecu tjelesne težine iznad 55 kg (koja god je doza niža), a uzima se jedanput na dan.
The usual daily dose is between 300 mg and 500 mg.
Uobičajena je dnevna doza između 300 mg i 500 mg.
The usual dose depends on your body surface area.
Uobičajena doza ovisi o površini Vašeg tijela.
The usual dose for adults and children aged above three months is 1 to 2 mg per kg body weight.
Uobičajena doza za odrasle i djecu stariju od tri mjeseca iznosi 1 do 2 mg po kg tjelesne težine.
The usual dose for adults is 20 mg in each infusion or injection.
Uobičajena doza za odrasle iznosi 20 mg u svakoj infuziji ili injekciji.
The usual dose for adults is 600 mg every 12 hours.
Uobičajena doza za odrasle je 600 mg svakih 12 sati.
The usual dose for adults with rheumatoid arthritis, ankylosing spondylitis, axial spondyloarthritis without radiographic evidence of ankylosing spondylitis, and for patients with psoriatic arthritis is 40 mg adalimumab given every other week as a single dose.
Uobičajena doza u odraslih osoba oboljelih od reumatoidnog artritisa, ankilozantnog spondilitisa, aksijalnog spondiloartritisa bez radiološkog dokaza AS-a te u bolesnika sa psorijatičnim artritisom iznosi 40 mg adalimumaba, a primjenjuje se kao pojedinačna doza svaki drugi tjedan.
The usual dose for children depends on the age and weight of the child and is given every 8 or 12 hours.
Uobičajena doza za djecu ovisi o dobi i tjelesnoj težini djeteta te se primjenjuje svakih 8 ili 12 sati.
The usual dose is 0.75 mg per m2 of body surface area once daily for 3 days.
Uobičajena doza je 0,75 mg po m2 tjelesne površine jedanput na dan tijekom 3 dana.
The usual dose is 0.75 mg per m2 of body surface area once daily for 3 days.
Uobičajena doza je 0,75 mg/m² površine tijela na dan tijekom 3 dana.
The usual dose is 1 mg per kg of your weight.
Uobičajena doza je 1 mg po kilogramu Vaše tjelesne težine.
The usual dose is 1 to 2 mg per kg body weight, i.e.
Uobičajena doza je 1 do 2 mg na kg tjelesne težine, tj.
The usual dose is 1.5 mg per m2 of body surface area once daily for 5 days.
Uobičajena doza je 1,5 mg/m² površine tijela na dan tijekom 5 dana.
The usual dose is 10 capsules (400 mg) inhaled in the morning, and 10 capsules inhaled in the evening.
Uobičajena doza je 10 kapsula (400 mg) inhaliranih ujutro i 10 kapsula inhaliranih uvečer.
The usual dose is 11 or 15 MBq per kg body weight, depending on your blood platelet count.
Uobičajena doza iznosi 11 ili 15 MBq po kilogramu tjelesne težine, ovisno o broju trombocita u krvi.
The usual dose is 15 MBq/kg body weight.
Uobičajena doza iznosi 15 MBq/kg tjelesne težine.
The usual dose is 160 mg (four capsules), taken at the same time once a day.
Uobičajena doza je 160 mg (četiri kapsule) i uzima se jedanput na dan u isto vrijeme.
The usual dose is 20 mg 5-ALA HCl per kilogram body weight.
Preporučena doza je 20 mg 5-ALA HCl po kilogramu tjelesne težine.
The usual dose is 300 mg once a day.
Uobičajena doza je 300 mg jedanput na dan.
The usual dose is 50 mg once a week.
Uobičajena doza je 50 mg jednom tjedno.
The usual dose is 600 IU per kilogram body weight twice a week.
Uobičajena doza je 600 IU po kilogramu tjelesne težine dva puta tjedno.
The usual dose is 650 mg/m2 of body surface area per day.
Uobičajena dnevna doza lijeka iznosi 650 mg/m2 površine tijela.
The usual dose is 90 micrograms for every 1 kilogram you weigh; you can repeat the injection every 2–3 hours until bleeding is controlled.
Uobičajena je doza 90 mikrograma po 1 kilogramu tjelesne težine: injiciranje možete ponoviti svaka 2-3 sata sve dok krvarenje nije pod kontrolom.
The usual dose is between 0.2 and 1.0 ml.
Uobičajena doza je između 0,2 i 1,0 ml.
The usual dose is one 300 mg tablet once a day.
Uobičajena doza je jedna tableta od 300 mg jedanput na dan.
The usual dose is one 50 mg tablet once a day; if you are taking certain other medicines (see section 2, earlier in this leaflet), the dose is one 50 mg tablet twice a day; or
Uobičajena doza je jedna tableta od 50 mg jedanput na dan; ako uzimate i neke druge lijekove (pogledajte dio 2. gore), doza je jedna tableta od 50 mg dvaput na dan.
The usual dose is one Aloxi capsule.
Uobičajena doza je jedna kapsula Aloxija.
The usual dose is one sachet applied once daily to dry, intact skin on the abdomen, upper arms/shoulders, or thighs, which delivers 4 mg of oxybutynin in 24 hours.
Uobičajena doza je jedna vrećica primijenjena jednom dnevno na suhu, neozlijeđenu kožu trbuha, nadlaktice/ramena, ili bedra, koja dostavlja 4 mg oksibutinina tijekom 24 sata.
The usual dose is one tablet daily.
Uobičajena doza je jedna tableta dnevno.
The usual dose is one tablet in the morning and one tablet in the evening.
Uobičajena doza je jedna tableta ujutro i jedna tableta uvečer.
The usual dose is one tablet of 60 mg twice a day.
Uobičajena doza je jedna tableta od 60 mg dvaput na dan.
The usual dose is one tablet once a day
Uobičajena doza je jedna tableta jedanput na dan.
The usual dose is recommended, except for decreased renal function with estimated glomerular filtration rate < 60 mL/min/1.73 m2 where Cholib is contraindicated (see section 4.3).
Preporučuje se uobičajena doza, osim kod smanjene funkcije bubrega s procijenjenom brzinom glomerularne filtracije <60 ml/min/1,73 m2 gdje je Cholib kontraindiciran (vidjeti dio 4.3).
The usual dose is the contents of one dispensed dose from the metering pump dispenser applied once daily to dry, intact skin on the abdomen, upper arms/shoulders, or thighs, which delivers 4 mg of oxybutynin in 24 hours.
Uobičajena doza je sadržaj jedne vrećice dostavljene distributorom odmjerne pumpice i primijenjene jednom dnevno na suhu, neozlijeđenu kožu trbuha, nadlaktice/ramena, ili bedra, kojim se dostavlja 4 mg oksibutinina tijekom 24 sata.
The usual dose is: from 1 to 6 years: 1 hard capsule of Wilzin 25 mg twice daily from 6 to 16 years if bodyweight under 57 kg: 1 hard capsule of Wilzin 25 mg three times daily from 16 years or if bodyweight above 57 kg: 2 hard capsules of Wilzin 25 mg or 1 hard capsule of Wilzin 50 mg three times daily.
Uobičajena doza je: od 1 do 6 godina: 1 tvrda kapsula Wilzina od 25 mg dva puta dnevno od 6 do 16 godina ako je tjelesna težina manja od 57 kg: 1 tvrda kapsula Wilzina od 25 mg tri puta dnevno od 16 godina ili ako je tjelesna težina veća od 57 kg: 2 tvrde kapsule Wilzina od 25 mg ili 1 tvrda kapsula Wilzina od 50 mg tri puta dnevno.
The usual dose of ARICLAIM is 60 mg once a day, but your doctor will prescribe the dose that is right for you.
Uobičajena doza lijeka ARICLAIM je 60 mg jednom na dan, no liječnik će Vam propisati dozu koja Vama najbolje odgovara.
The usual dose of AZILECT is 1 tablet of 1 mg taken by mouth once daily.
Uobičajena doza AZILECT-a je 1 tableta od 1 mg uzeta na usta jedanput dnevno.
The usual dose of Bemfola is 150 IU (0.25 ml) together with hCG.
Uobičajena doza lijeka Bemfola je 150 IU (0,25 ml) zajedno s hCG-om.
The usual dose of CELSENTRI is 150 mg, 300 mg or 600 mg twice per day depending on other medicines that you are taking at the same time as CELSENTRI.
Uobičajena doza lijeka CELSENTRI je 150 mg, 300 mg ili 600 mg dva puta na dan ovisno o ostalim lijekovima koje primjenjujete istovremeno kad i CELSENTRI.
The usual dose of Ceplene is 0.5 mL of solution twice a day given as a slow subcutaneous injection (in the layer of tissue just under the skin).
Uobičajena doza Ceplenea je 0,5 mL otopine dvaput dnevno davana kao spora potkožna injekcija (u sloj tkiva odmah ispod kože).
The usual dose of Combivir is one tablet twice a day.
Uobičajena doza Combivira je jedna tableta dva puta na dan.
The usual dose of Copalia is one tablet per day.
Uobičajena doza Copaliaa je jedna tableta na dan.
The usual dose of Cymbalta is 60 mg once a day, but your doctor will prescribe the dose that is right for you.
Uobičajena doza lijeka Cymbalta je 60 mg jednom na dan, no liječnik će Vam propisati dozu koja Vama najbolje odgovara.
The usual dose of Duloxetine Lilly is 60 mg once a day, but your doctor will prescribe the dose that is right for you.
Uobičajena doza lijeka Duloksetin Lilly je 60 mg jednom na dan, no liječnik će Vam propisati dozu koja Vama najbolje odgovara.
The usual dose of Epivir is 30 ml (300 mg) a day.
Uobičajena doza lijeka Epivir je 30 ml (300 mg) na dan.
The usual dose of Epivir is 4 mg/kg twice daily (leaving approximately 12 hours between each dose), or 8mg/kg once a day, up to a maximum total daily dose of 300 mg daily.
Uobičajena doza lijeka Epivir je 4 mg/kg dvaput na dan (s razmakom od približno 12 sati između doza) ili 8 mg/kg jedanput na dan, do maksimalne ukupne doze od 300 mg na dan.
The usual dose of Ferriprox is 75 mg per kilogram body weight each day, divided into three separate doses.
Uobičajena doza lijeka Ferriprox jest 75 mg po kilogramu težine svakog dana, podijeljena u tri odvojene doze.
The usual dose of GONAL-f is 150 IU (0.24 mL) together with hCG.
Uobičajena doza GONAL-f je 150 IU (0,24 ml) zajedno s hCG-om.
The usual dose of HALAVEN is
Uobičajena je doza lijeka HALAVEN
The usual dose of Lamivudine Teva is one tablet (100 mg lamivudine) once a day.
Uobičajena doza lijeka Lamivudin Teva je jedna tableta (100 mg lamivudina) jedanput na dan.
The usual dose of Lamivudine Teva Pharma B.V. is 150 mg a day.
Uobičajena doza lijeka Lamivudin Teva Pharma B.V. je 150 mg na dan.
The usual dose of Lamivudine Teva Pharma B.V. is 225 mg a day.
Uobičajena doza lijeka Lamivudin Teva Pharma B.V. je 225 mg na dan.
The usual dose of Lamivudine Teva Pharma B.V. is 300 mg a day.
Uobičajena doza lijeka Lamivudin Teva Pharma B.V. je 300 mg na dan.
The usual dose of Lamivudine/Zidovudine Teva is one tablet twice a day.
Uobičajena doza Lamivudina/Zidovudina Teva je jedna tableta dva puta na dan.
The usual dose of Nuwiq is 20 to 40 IU per kg body weight, given every 2 to 3 days.
Uobičajena doza Nuwiqa je od 20 do 40 IU po kg tjelesne težine, a daje se svaka 2-3 dana.
The usual dose of Pegasys, given in combination with ribavirin, is based on your child’s height and weight.
Uobičajena doza lijeka Pegasys, primijenjena u kombinaciji s ribavirinom, temelji se na visini i tjelesnoj težini Vašeg djeteta.
The usual dose of PREZISTA is 800 milligram (2 tablets containing 400 milligram of PREZISTA or 1 tablet containing 800 milligram of PREZISTA) together with 100 milligram ritonavir once daily.
Uobičajena doza lijeka PREZISTA je 800 miligrama (2 tablete koje sadrže 400 miligrama lijeka PREZISTA ili 1 tableta koja sadrži 800 miligrama lijeka PREZISTA) zajedno sa 100 miligrama ritnavira jednaput na dan.
The usual dose of PREZISTA is 800 milligram once daily.
Uobičajena doza lijeka PREZISTA je 800 miligrama jedanput na dan.
The usual dose of Rasagiline ratiopharm is 1 tablet of 1 mg taken by mouth once daily.
Uobičajena doza Razagilin ratiopharma je 1 tableta od 1 mg uzeta na usta jedanput dnevno.
The usual dose of RoActemra is 8 mg per kg of body weight.
Uobičajena doza lijeka RoActemra je 8 mg po kilogramu tjelesne težine.
The usual dose of this medicine is 150 IU together with hCG.
Uobičajena doza ovog lijeka je 150 IU zajedno s hCG.
The usual dose of Xeristar is 60 mg once a day, but your doctor will prescribe the dose that is right for you.
Uobičajena doza lijeka Xeristar je 60 mg jednom na dan, no liječnik će Vam propisati dozu koja Vama najbolje odgovara.
The usual dose of Zeffix is 20 ml (100 mg lamivudine) once a day.
Uobičajena doza lijeka Zeffix je 20 ml (100 mg lamivudina) jedanput na dan.
The usual dose of Zeffix is one tablet (100 mg lamivudine) once a day.
Uobičajena doza lijeka Zeffix je jedna tableta (100 mg lamivudina) jedanput na dan.
The usual dose of Ziagen is 600 mg (30 ml) a day.
Uobičajena doza lijeka Ziagen je 600 mg (30 ml) na dan.
The usual dose of Zoledronic Acid Accord is one infusion of 4 mg over at least 15 minutes.
Uobičajena doza lijeka Zoledronatna kiselina Accord je jednokratna intravenska infuzija od 4mg u trajanju od najmanje 15 minuta.
The usual dose range is 15 to 30 micrograms for every 1 kilogram you weigh, for each injection.
Uobičajeni je raspon doze 15 do 30 mikrograma po 1 kilogramu tjelesne težine, za svaku injekciju.
The usual dose regimen for Crohn’s disease is 80 mg initally followed by 40 mg every other week two weeks later.
Uobičajena početna doza lijeka Humira je 80 mg, nakon čega poslije dva tjedna slijedi doza od 40 mg.
The usual dose regimen for Crohn’s disease is 80 mg initially followed by 40 mg every other week two weeks later.
Uobičajena početna doza lijeka Humira je 80 mg, nakon čega poslije dva tjedna slijedi doza od 40 mg.
The usual dose regimen for hidradenitis suppurativa is an initial dose of 160 mg (as 4 injections in one day or 2 injections per day for two consecutive days), followed by an 80 mg dose (as 2 injections on the same day) two weeks later.
Uobičajen režim doziranja za gnojni hidradenitis je početna doza od 160 mg (u obliku 4 injekcije u jednom danu ili 2 injekcije na dan, tijekom dva uzastopna dana), nakon koje se dva tjedna kasnije primjenjuje doza od 80 mg (u obliku 2 injekcije u istom danu).
The usual dose regimen for Rapamune is a 6 mg single oral loading dose, administered as soon as possible after transplantation, followed by 2 mg once daily until results of therapeutic monitoring of the medicinal product are available (see Therapeutic monitoring of the medicinal product and dose adjustment).
Uobičajeni režim doziranja Rapamunea je jednokratna udarna oralna doza od 6 mg, koja se mora primijeniti što je ranije moguće nakon transplantacije, nakon čega slijedi 2 mg jedanput dnevno dok rezultati terapijskog praćenja lijeka ne postanu dostupni (vidjeti Terapijsko praćenje lijeka i prilagodba doze).
The usual dose regimen is 80 mg initially followed by 40 mg two weeks later.
Uobičajena početna doza lijeka Humira je 80 mg, nakon čega poslije dva tjedna slijedi doza od 40 mg.
The usual dose to prevent invasive Candida infections is 2 mg/kg per day.
Uobičajena doza za sprječavanje invazivnih infekcija Candidom je 2 mg/kg/dan
The usual dose to prevent invasive Candida infections is 50 mg per day for patients weighing more than 40 kg and 1 mg/kg per day for patients weighing 40 kg or less.
Uobičajena doza za sprječavanje invazivnih infekcija Candidom je 50 mg na dan za bolesnike tjelesne težine veće od 40 kg i 1 mg/kg na dan za bolesnike tjelesne težine 40 ili manje kilograma.
The usual dose to prevent invasive Candida infections is 50 mg per day for patients weighing more than 40 kg and 1 mg/kg per day for patients weighing 40 kg or less.
Uobičajena doza za sprječavanje invazivnih infekcija Candidom je 50 mg na dan za bolesnike tjelesne težine veće od 40 kg i 1 mg/kg na dan za bolesnike tjelesne težine od 40 ili manje kilograma.